ArticleJournal of pharmaceutical health care and sciences2025

A case of hepatitis B virus reactivation after elranatamab therapy in a patient with multiple myeloma.

Naoaki Nishimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.